Watch Ticker

Ligand Pharmaceuticals Inc.

Go to Ligand Pharmaceuticals Inc. Website

$135.15

-0.24 (-0.18%)

Live

Previous Close

$135.39

Day Range

$132.7 - $135.88

Previous Day Range

$131.67 - $135.39

Market Cap

$2.6 billion USD

Day Vol.

185753

Previous Day Vol.

103535

Currency

USD

Primary Exchange

Nasdaq

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Lig...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Ligand Pharmaceuticals and Channel Therapeutics announced a merger agreement, where Ligand's Pelthos Therapeutics subsidiary will be combined with Channel. The combined company will focus on commercializing Pelthos' FDA-approved ZELSUVMI for the treatment of Molluscum contagiosum infections.

Related tickers: LGND, CHRO.

Read Full Article

Globe Newswire - Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer

Palvella Therapeutics, a clinical-stage biopharmaceutical company, has appointed Matthew E. Korenberg as its new Chief Financial Officer. Korenberg brings over 27 years of senior executive experience in the biotech and healthcare investment banking industries.

Related tickers: LGND, LFCR.

Read Full Article

Trending Tickers

Please sign in to view